Drugs / neutral protamine insulin
neutral protamine insulin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01310452 | Jan 2011 → ? | type 2 diabetes mellitus | Fudan University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | neutral protamine insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01310452 ↗ |
| Known as | human isophane insulin | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |
| Known as | neutral protamine Hagedorn | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |
| Modality | Protein / enzyme biologic | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |